Sitemap
Pages
- Cookie Policy
- Dosage Forms
- Home Page
- Markets Served
- Our Story
- Resource Center
- Services
- Analytical Services
- Biopharmaceutical
- Clinical Drug Product Manufacturing
- Commercial Drug Product Manufacturing
- Dexamethasone-Loaded Silicone for Implantable Systems
- Drug / Device Combination Products
- Drug Product Manufacturing
- FDA-Inspected Aseptic Manufacturing Facility and Services
- Feasibility Programs
- Formulation
- ICH Stability Programs
- Long Acting Drug Delivery
- Long-Acting Implant Feasibility Program
- Microsphere and Nanotechnology Development
- Microsphere Feasibility Program for Long-Acting Injectables
- Nanomilling Feasibility Program
- Pre-clinical Drug Product Manufacturing
- Proprietary Technology
- Solubility Improvement and Bioavailability Enhancement
Resources
- Guide to Inhalation and Respiratory Aerosol Drug Delivery: Leveraging CDMO Expertise
- Complete Guide to Pre-Clinical Drug Product Manufacturing
- The Guide to Cryomilling and Refining Polymer Powders
- Meet the Machine: The Bausch 515 Aseptic Filling & Closing Machine
- What to Expect From Your Nanomilling Partner or Company
- How to Enhance the Solubility of Ocular Drug Products
- How to Select the Right CDMO for Your Sterile Drug Product in 2023
- Solving Bioavailability Challenges Using A Drug Product’s Target Product Profile (TPP)
- Bridging Clinical and Commercial Drug Product Manufacturing – Outsourcing Advice from a CDMO
- Ocular Implants for Drug Delivery: Improving Patient Outcomes
- Nasal Drug Formulation: A Guide to Successful Drug Product Development
- A Guide to Drug Development for Biologics: Overcoming Formulation and Manufacturing Challenges
- 2024 Pharma Trends Shaping the CDMO Industry Outlook
- Phase Appropriate Filter Validation for Sterile Drug Product Manufacturing
- Filter Validation: Key Elements for Sterile Drug Product Manufacturing
- A 2024 Guide to Solubility Improvement and Bioavailability Enhancement Techniques
- A Pharmaceutical Guide to Cannabis – FAQs for Drug Product Development
- A 2023 Guide to Vaccine Development & Immunization
- The Guide to Analytical Method Development
- Targeted Therapeutics and Nanoparticles
- Key Takeaways From the FDA Complex Generic Drug Product Development Workshop: Part 2
- Key Takeaways From the FDA Complex Generic Drug Product Development Workshop: Part 1
- Considerations in Particle Sizing – Part 1: Classification of the Various Sizing Techniques
- Code of Federal Regulations Title 21 Part 11 Requirements
- In Vitro Dissolution Testing For Solid Oral Dosage Forms
- How Personalized Medicine is Evolving the CDMO Landscape
- Physical Stability of Disperse Systems
- Drug Substance Solid State Characterization
- Biopharmaceutical Classification System
- Solid Lipid Nanoparticles
- Glossary of Nanotech
- Quality by Design
- Process Analytical Technology
- Phase Behavior of Surface-Active Solutes
- Cubic Phase Particles
- Solid Solutions and Dispersions
- Overview of the Zeta Potential
- Nanotechnology – New Name – Old Science
- Solubility – Ideal Solubility & Solubility Models
- Sampling of Powders
- Potent Compound Handling Operations
- Hot Melt Extrusion
- Emulsion Stability and Testing
- Glossary of Polymer Terms
- Encapsulation
- Mechanical Dispersing of Insoluble APIs
- Dissolution Testing for OSD
- The Patent Process
- Dissolving Films
- Combination Devices
- Surfactants
- Development and Validation of In Vitro Release Testing for Semisolid Formulations
- Emulsions and Emulsifications
- Protein Structure: Primary, Secondary, Tertiary, Quatemary Structures
- Considerations in Particle Sizing – Part 2: Specifying a Particle Size Analyzer
- Analytical Method Development and Validation
- Mass Spectrometry in Bioanalysis
- Skin and Nail: Barrier Function, Structure, and Anatomy Considerations for Drug Delivery
- Particle Size Distribution and Its Measurement
- Lyophilization of Pharmaceuticals: An Overview
- Orphan Drug Product Development: Incentives and Outsourcing Considerations
- Understanding Analytical Method Validation with Laurie Goldman
- The FDA’s Recent Uptick in Ophthalmic NDA & BLA Approvals
- Overcoming Solubility Challenges: Techniques to Improve Dissolution Rate and Increase Bioavailability
- Highly Potent API (HPAPI) Handling: An Expert Interview with Judy Cohen
- Aseptic Manufacturing and Sterile Fill-Finish for Complex Drug Products
- 6 Takeaways from the FDA’s Complex Generic Drug Product Development Workshop
- Hot Melt Extrusion: Solubility Enhancement, Controlled Release, and More
- Why the FDA Loves Complex Generic Drug Products
- Nanomilling: A Key Option for Formulating Water-Insoluble APIs
- What are Complex Drug Products and Why Should You Care?